A detailed history of First Turn Management, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, First Turn Management, LLC holds 959,703 shares of ROIV stock, worth $19.5 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
959,703
Holding current value
$19.5 Million
% of portfolio
2.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$10.74 - $15.28 $10.3 Million - $14.7 Million
959,703 New
959,703 $14.5 Billion
Q4 2023

Feb 07, 2024

BUY
$8.38 - $11.58 $11.4 Million - $15.8 Million
1,363,504 New
1,363,504 $15.3 Billion

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $14.3B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.